Synergia Medical
PrivateLast Round
Series B
Extension
Jan 18, 2023
Total Funding Raised
$29.77M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Synergia Medical operates in Healthcare & Life Sciences and is based in Brussels. Its latest recorded funding round was a Series B Extension round in January 2023.
Synergia Medical is a medical device company that develops next-generation, optoelectronic neurostimulation technologies for the treatment of drug-resistant epilepsy.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Synergia Medical Comparables
Compare Synergia Medical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cadence Neuroscience | 84% | |
| LivaNova | 77% | |
| NeuroPace | 72% |
For institutional investors. Book with your work email.
Synergia Medical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Jan 18, 2023 | ||||
| Grant | Oct 19, 2022 | ||||
| Series B | Sep 12, 2022 | ||||
| Accelerator | Jun 22, 2020 | ||||
| Series A | Feb 19, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Synergia Medical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Federal Holding and Investment Company | Series A, Series B |
| European Innovation Council Fund | Grant |
| Newton Biocapital | Series B, Series A |
| MedTech Innovator | Accelerator |
| Société Régionale d'Investissement de Wallonie | Series A |
| Investsud | Series B, Series B Extension |
| Nivelinvest | Series B, Series B Extension |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 88% MoM.
- Feb 1, 2025
Attila Borbath stepping down, Charles Nolet to succeed him February 1, 2025.
For institutional investors. Book with your work email.
Synergia Medical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Synergia Medical's valuation, stock price, and market status.
Is Synergia Medical a public or private company?
Synergia Medical is a private company.
What is the current stock price of Synergia Medical?
Synergia Medical is a private company, so its shares have no public market price. Caplight tracks Synergia Medical's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Synergia Medical worth (valuation)?
Valuation information for Synergia Medical is not publicly available.
Can I buy Synergia Medical stock?
Synergia Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Synergia Medical's last funding round?
Synergia Medical's most recent funding round was Series B Extension on January 18, 2023.
Who are the main investors in Synergia Medical?
Key investors in Synergia Medical include Newton Biocapital.
Will Synergia Medical IPO soon?
No public IPO plans have been announced for Synergia Medical.
How can I track Synergia Medical secondary market activity?
Caplight tracks bids, offers, and trades in Synergia Medical's shares on secondary markets.